A method for manufacturing a molded part while changing between multiple molds including a first ejecting step of opening a first mold and ejecting the molded part from the first mold, a checking step of checking the ejected molded part to determine if the molded part is acceptable, a first injecting step of closing the first mold and performing injection into the first mold, a second ejecting step of, where the ejected molded part is determined to be acceptable, changing the first mold to a second mold and ejecting the molded part from the second mold after the first injecting step, and a third ejecting step of, in a case where the molded part ejected in the first ejecting step is determined to be non-acceptable, not changing the first mold to the second mold and ejecting the molded part from the first mold.

A method for manufacturing a molded part while changing between multiple molds including a first ejecting step of opening a first mold and ejecting the molded part from the first mold, a checking step of checking the ejected molded part to determine if the molded part is acceptable, a first injecting step of closing the first mold and performing injection into the first mold, a second ejecting step of, where the ejected molded part is determined to be acceptable, changing the first mold to a second mold and ejecting the molded part from the second mold after the first injecting step, and a third ejecting step of, in a case where the molded part ejected in the first ejecting step is determined to be non-acceptable, not changing the first mold to the second mold and ejecting the molded part from the first mold.

A menstrual cup includes a receptacle having an exterior surface and an interior surface, the interior surface defining at least in part an interior cavity adapted for collecting fluid, the receptacle further extending from an open top end to a closed bottom end, the open top end having a predetermined diameter, the receptacle further including an upper rim portion at the open top end of the receptacle, and a main portion defining a decreasing diameter of the interior cavity while extending downwards from the open top end to the closed bottom end of the receptacle. Furthermore, the receptacle is at least partly formed of a renewable thermoplastic elastomer.

Disclosed are nasal dressings and nasal stents comprising a collagen foam. Also disclosed are methods of making and using such nasal dressings and nasal stents. In an embodiment, a nasal dressing or nasal stent is formed by a method comprising the steps of: forming an aqueous mixture of from 5 to 25 wt % of acid-soluble collagen and from 75 to 95 wt % of collagen fibers, both based on the total solids content of the aqueous mixture, placing the aqueous mixture into a mold, freeze-drying the aqueous mixture while in the mold, thereby forming a collagen foam, and cross-linking the collagen foam.

Disclosed are nasal dressings and nasal stents comprising a collagen foam. Also disclosed are methods of making and using such nasal dressings and nasal stents. In an embodiment, a nasal dressing or nasal stent is formed by a method comprising the steps of: forming an aqueous mixture of from 5 to 25 wt % of acid-soluble collagen and from 75 to 95 wt % of collagen fibers, both based on the total solids content of the aqueous mixture, placing the aqueous mixture into a mold, freeze-drying the aqueous mixture while in the mold, thereby forming a collagen foam, and cross-linking the collagen foam.

Provided herein are methods for decreasing the toxicity of advanced ablative cancer therapies on neighboring organs. The methods herein provide spacing between single or multiple tumor cites and immediate healthy organs while maintaining or increasing patient quality of life. Such toxicity isolation can be performed by inserting a spacer around the one or more tumor cites, which can be performed concurrently with fiducial marker placement.

Provided herein are methods for decreasing the toxicity of advanced ablative cancer therapies on neighboring organs. The methods herein provide spacing between single or multiple tumor cites and immediate healthy organs while maintaining or increasing patient quality of life. Such toxicity isolation can be performed by inserting a spacer around the one or more tumor cites, which can be performed concurrently with fiducial marker placement.

A medical device includes: a substrate layer; an adhesive layer formed on at least a part of the substrate layer and containing a hydrophilic copolymer (1) containing a structural unit derived from a polymerizable monomer (A) having a sulfobetaine structure, a structural unit derived from a polymerizable monomer (B) having at least one group selected from the group consisting of a sulfonic acid group (—SO.sub.3H), a sulfuric acid group (—OSO.sub.3H), a sulfurous acid group (—OSO.sub.2H), and salt groups thereof, and a structural unit derived from a polymerizable monomer (C) having a photoreactive group; and a surface lubricious layer formed on at least a part of the adhesive layer and containing a polymer containing a structural unit derived from acrylamide and a hydrophilic copolymer (2).

Bioabsorbable scaffolds having high crush recoverability, high fracture resistance, and reduced or no recoil due to self expanding properties at physiological conditions are disclosed. The scaffolds are made from a random copolymer of PLLA and a rubbery polymer such as polycaprolactone.

Bioabsorbable scaffolds having high crush recoverability, high fracture resistance, and reduced or no recoil due to self expanding properties at physiological conditions are disclosed. The scaffolds are made from a random copolymer of PLLA and a rubbery polymer such as polycaprolactone.